Israeli 3-D printer firm Nano Dimension has successfully lab-tested a 3-D bioprinter for stem cells, paving the way for the potential printing of large tissues and organs, the company said on Wednesday. While 3-D printers are used already to create stem cells for research, Nano Dimension said the trial, conducted with Israeli biotech firm Accellta Ltd, showed its adapted printer could make large volumes of high resolution cells quickly. Trading in Nano Dimension shares was halted in Tel Aviv, pending the publication of a significant announcement. By combining Nano Dimension's high speed ink jet capabilities with Accellta's stem cell suspension technologies, Nano Dimension Chief Executive Officer Amit Dror said they could "enable 3-D printing at high resolution and high volumes". "Accellta's technology can deliver large quantities of high quality cells which can be an enabler for printing even large and complex tissues and organs," they said.

Source: Fox News May 25, 2016 04:26 UTC